|
MBD4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.462100E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.317600E-02 |
| Normal-vs-Stage2 |
1.028170E-01 |
| Normal-vs-Stage3 |
9.185800E-02 |
| Normal-vs-Stage4 |
1.672160E-01 |
| Stage1-vs-Stage2 |
7.753000E-01 |
| Stage1-vs-Stage3 |
9.714000E-01 |
| Stage1-vs-Stage4 |
7.542600E-01 |
| Stage2-vs-Stage3 |
7.750800E-01 |
| Stage2-vs-Stage4 |
6.544800E-01 |
| Stage3-vs-Stage4 |
8.231000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.081900E-02 |
| Normal-vs-AfricanAmerican |
6.772200E-02 |
| Normal-vs-Asian |
2.004400E-01 |
| Caucasian-vs-AfricanAmerican |
6.318800E-01 |
| Caucasian-vs-Asian |
9.392200E-01 |
| AfricanAmerican-vs-Asian |
6.856400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.441600E-03 |
| Normal-vs-Female |
8.371200E-01 |
| Male-vs-Female |
3.83379999999711E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.057830E-01 |
| Normal-vs-Age(41-60Yrs) |
2.000800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.049900E-02 |
| Normal-vs-Age(81-100Yrs) |
7.839000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.742000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.055400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.922000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.913200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.269900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.187600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.300400E-01 |
| Normal-vs-Grade 2 |
9.528000E-02 |
| Normal-vs-Grade 3 |
2.640200E-02 |
| Normal-vs-Grade 4 |
7.238100E-02 |
| Grade 1-vs-Grade 2 |
1.414820E-01 |
| Grade 1-vs-Grade 3 |
7.817600E-02 |
| Grade 1-vs-Grade 4 |
2.543600E-02 |
| Grade 2-vs-Grade 3 |
3.904000E-01 |
| Grade 2-vs-Grade 4 |
4.551600E-01 |
| Grade 3-vs-Grade 4 |
8.844600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.900620E-01 |
| Normal-vs-ccB subtype |
2.820300E-02 |
| ccA subtype-vs-ccB subtype |
1.276560E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.488200E-02 |
| Normal-vs-N1 |
3.734400E-01 |
| N0-vs-N1 |
1.382190E-01 |
|
|
